We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Biotage AB and McMaster University Sign Agreement to Develop new Chemistry Platform

News   Feb 26, 2007

 
Biotage AB and McMaster University Sign Agreement to Develop new Chemistry Platform
 
 
 

RELATED ARTICLES

Insights on Marijuana and Opioid Use in People With Cancer

News

A new study reveals that many people with cancer use marijuana, and rates of use in the U.S. have increased over time.

READ MORE

Triple-negative Breast Cancers Can Adopt Reversible State That is Resistant to Chemotherapy

News

Researchers have discovered that triple-negative breast cancer (TNBC) cells can develop resistance to frontline, or neoadjuvant, chemotherapy not by acquiring permanent adaptations, but rather transiently turning on molecular pathways that protect the cells.

READ MORE

On-chip Drug Screening for Identifying Antibiotic Interactions in Eight Hours

News

A research team developed a microfluidic-based drug screening chip that identifies synergistic interactions between two antibiotics in eight hours. This chip can be a cell-based drug screening platform for exploring critical pharmacological patterns of antibiotic interactions, along with potential applications in screening other cell-type agents and guidance for clinical therapies.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE